Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Given Consensus Rating of “Buy” by Brokerages

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) has earned an average rating of “Buy” from the six ratings firms that are covering the stock, Marketbeat.com reports. Four research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. The average 12-month price target among analysts that have issued ratings on the stock in the last year is $12.13.

Several brokerages have recently weighed in on BIOX. Canaccord Genuity Group lowered their price target on shares of Bioceres Crop Solutions from $10.00 to $9.50 and set a “buy” rating on the stock in a research report on Wednesday, November 13th. Oppenheimer decreased their target price on Bioceres Crop Solutions from $16.00 to $13.00 and set an “outperform” rating on the stock in a research note on Monday, October 21st.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the stock. JPMorgan Chase & Co. raised its position in Bioceres Crop Solutions by 49.3% in the 3rd quarter. JPMorgan Chase & Co. now owns 89,973 shares of the company’s stock valued at $708,000 after purchasing an additional 29,693 shares in the last quarter. Stifel Financial Corp raised its holdings in Bioceres Crop Solutions by 33.4% in the third quarter. Stifel Financial Corp now owns 40,790 shares of the company’s stock valued at $321,000 after acquiring an additional 10,224 shares in the last quarter. Fourth Sail Capital LP lifted its stake in Bioceres Crop Solutions by 61.6% in the third quarter. Fourth Sail Capital LP now owns 3,171,102 shares of the company’s stock worth $24,957,000 after acquiring an additional 1,209,277 shares during the last quarter. Long Focus Capital Management LLC grew its holdings in Bioceres Crop Solutions by 19.9% during the 2nd quarter. Long Focus Capital Management LLC now owns 280,547 shares of the company’s stock worth $3,145,000 after acquiring an additional 46,647 shares in the last quarter. Finally, Dimensional Fund Advisors LP increased its position in shares of Bioceres Crop Solutions by 9.5% in the 2nd quarter. Dimensional Fund Advisors LP now owns 61,330 shares of the company’s stock valued at $688,000 after purchasing an additional 5,341 shares during the last quarter. 17.68% of the stock is currently owned by hedge funds and other institutional investors.

Bioceres Crop Solutions Stock Down 1.5 %

Shares of NASDAQ BIOX opened at $6.44 on Tuesday. The stock has a market cap of $404.74 million, a PE ratio of 322.16 and a beta of 0.56. The company has a current ratio of 1.27, a quick ratio of 0.87 and a debt-to-equity ratio of 0.37. Bioceres Crop Solutions has a 12-month low of $5.71 and a 12-month high of $14.05. The company has a 50-day moving average of $6.54 and a 200 day moving average of $8.36.

Bioceres Crop Solutions (NASDAQ:BIOX) last posted its quarterly earnings results on Monday, November 11th. The company reported ($0.09) EPS for the quarter, missing the consensus estimate of $0.02 by ($0.11). The company had revenue of $92.60 million during the quarter, compared to analyst estimates of $117.15 million. Bioceres Crop Solutions had a net margin of 0.53% and a return on equity of 0.68%. During the same period in the prior year, the business posted ($0.07) EPS. As a group, sell-side analysts predict that Bioceres Crop Solutions will post 0.12 EPS for the current fiscal year.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.